LEWISVILLE, Texas--(BUSINESS WIRE)--
Orthofix International N.V. (NASDAQ:OFIX), a diversified, global medical
device company, today announced that it will participate in the 34th
Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2016
at the Westin St. Francis Hotel in San Francisco, California. President
and Chief Executive Officer Brad Mason will represent the Company in a
presentation scheduled for 8:00 a.m. Pacific Time.
A live audio webcast will be available on the Company's website at www.orthofix.com
by clicking on the Investors tab and then clicking the link on the
Events and Presentations page.
About Orthofix
Orthofix International N.V. is a diversified, global medical device
company focused on improving patients' lives by providing superior
reconstructive and regenerative orthopedic and spine solutions to
physicians worldwide. Headquartered in Lewisville, Texas, the Company
has four strategic business units that include BioStim, Biologics,
Extremity Fixation and Spine Fixation. Orthofix products are widely
distributed via the Company's sales representatives, distributors and
its subsidiaries. In addition, Orthofix is collaborating on research and
development activities with leading clinical organizations such as the
Musculoskeletal Transplant Foundation and the Texas Scottish Rite
Hospital for Children. For more information, please visit www.orthofix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160104006538/en/
Orthofix, Inc.
Investor Relations:
Mark Quick, 214-937-2924
markquick@orthofix.com
or
Media
Relations:
Denise Landry, 214-937-2529
deniselandry@orthofix.com
Source: Orthofix International N.V.
News Provided by Acquire Media